Posey Biothane Restraint Cuffs, Catalog Number 2900. The device is intended to limit a patient's movement to the extent necessary for treatment or protection of the patient or others.
Publicado el 17 de abril de 2013 · Inicio del retiro: 31 de octubre de 2012
Resumen
FDA registra el retiro Z-1071-2013 de dispositivos médicos de Clase II, publicado el 17 de abril de 2013 e iniciado el 31 de octubre de 2012. Empresa responsable: J T Posey Company; Estado: Finalizado; Cantidad reportada: 1673 units; Lote: The model/catalog number for the device is 2900. All lots are being recalled. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The firm voluntarily recalled Biothane Restraint Cuffs, Catalog No. 2900, that did not meet the required specifications for tensile strength. Failure of these rivets could allow the cuff to become disconnected from the connecting strap and allow patients to regain free use of the limb.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- J T Posey Company
- Distribuidor
- Nationwide Distribution
- Lote
- The model/catalog number for the device is 2900. All lots are being recalled.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAIMPAX CV Reporting Cardiac Catheterization module and IMPAX CV Outbound Reporting. Facilitates digital reports17 de abril de 2013
- FDAPrecise Treatment Table. To be used as part of radiation therapy treatment process.17 de abril de 2013
- FDAIMPAX CV 7.8 SU3 - OCR Service. The IMPAX CV Reporting component facilitates the quick , effective creation of17 de abril de 2013
- FDADade(R) Actin(R) FSL Activated PTT Reagent. For use in the determination of the activated partial17 de abril de 2013
- FDAToshiba TSX-30IC AQUlLlON ONE System, Computed Tomography X-Ray. This system supports Whole body scanning.17 de abril de 2013
- FDAG7 HPLC. Used as an aid in the detection and presumptive identification of abnormal hemoglobins in whole17 de abril de 2013
Preguntas sobre este retiro
¿Posey Biothane Restraint Cuffs, Catalog Number 2900. The device is intended to limit a patient's movement to the extent necessary for treatment or protection of the patient or others. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1071-2013 el 17 de abril de 2013. Peligro reportado: The firm voluntarily recalled Biothane Restraint Cuffs, Catalog No. 2900, that did not meet the required specifications for tensile strength. Failure of these rivets could allow the cuff to become disconnected from the connecting strap and allow patients to regain free use of the limb.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter